Truist Financial Forecasts Strong Price Appreciation for Guardian Pharmacy Services (NYSE:GRDN) Stock

Guardian Pharmacy Services (NYSE:GRDN) had its price objective raised by equities research analysts at Truist Financial from $28.00 to $30.00 in a research report issued to clients and investors on Friday, Marketbeat Ratings reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price objective indicates a potential upside of 15.01% from the stock’s current price.

Separately, Wall Street Zen upgraded Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a research note on Sunday, August 17th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $26.33.

Guardian Pharmacy Services Trading Up 2.5%

Guardian Pharmacy Services stock opened at $26.08 on Friday. The stock has a 50 day moving average of $24.57 and a 200-day moving average of $22.89. The stock has a market cap of $1.65 billion and a P/E ratio of -17.16. Guardian Pharmacy Services has a 52 week low of $15.52 and a 52 week high of $30.39.

Institutional Trading of Guardian Pharmacy Services

A number of institutional investors have recently added to or reduced their stakes in GRDN. Brown Advisory Inc. lifted its position in Guardian Pharmacy Services by 5.0% during the 2nd quarter. Brown Advisory Inc. now owns 1,682,476 shares of the company’s stock worth $35,854,000 after acquiring an additional 79,652 shares during the last quarter. Franklin Resources Inc. boosted its position in shares of Guardian Pharmacy Services by 32.2% during the 2nd quarter. Franklin Resources Inc. now owns 976,207 shares of the company’s stock valued at $20,803,000 after acquiring an additional 237,630 shares in the last quarter. TimesSquare Capital Management LLC bought a new position in Guardian Pharmacy Services during the second quarter worth about $17,351,000. Wellington Management Group LLP grew its stake in shares of Guardian Pharmacy Services by 14.2% in the 1st quarter. Wellington Management Group LLP now owns 464,924 shares of the company’s stock valued at $9,884,000 after purchasing an additional 57,924 shares during the period. Finally, Woodline Partners LP raised its holdings in shares of Guardian Pharmacy Services by 1.5% in the 1st quarter. Woodline Partners LP now owns 421,203 shares of the company’s stock worth $8,955,000 after buying an additional 6,083 shares in the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.